Stock · INDGN · Healthcare
INDGN share price target 2026
Support, resistance, the F&O structure and the BazaarBaazi Crack Score for Indegene Limited, refreshed every end-of-day run. A systematic, data-only read on Indegene Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
The verdict
BazaarBaazi reads INDGN as two-way with a Crack Score of 49/100 as of 21 Jul 2026.
BazaarBaaziSource & method
The scanner's readScanned · scanned 21 Jul 2026
Where INDGN stands on the 500-name BazaarBaazi setup scanner: technicals, filed fundamentals and money flow read together, refreshed every run.
Scanned and scored this run, but the evidence is incomplete or conflicted. The engine fails closed to NO_TRADE.
Technical axis
80/100Fundamental axis
33/100Money flow
49/100Result pulse · Q4 FY26
0/100Technical evidence
price below 50DMA
price below 150DMA
price below 200DMA
200DMA falling
Valuation and context
P/E 30.3 vs sector median 50.4 (0.6x, 17th pctile)
P/E 0.98x its own ~15m median (30.9)
Red flags
below 200DMA (not a long-side trend)
weak filed result (score 0.0)
Relative valuation
P/E (TTM)
30.3P/E vs sector
+0.6%Sector percentile
17PEG
n/aScanner levels from the deterministic engine run of 2026-07-21, not a SEBI-registered recommendation and not investment advice. The fundamental axis reads the official filing: Q4 FY26 result.
Price target: support and resistanceComputed 21 Jul 2026
Support and resistance for INDGN are read inside the latest show; no spot was printed in the most recent editorial note.
Levels are read inside the latest show. The most recent editorial reference is Systematic Read on 21 Jul 2026.
These are structural reference lines, not a SEBI-registered price target. BazaarBaazi is independent media; the levels frame how the desk reads the INDGN chart, refreshed every end-of-day run.
The Crack Score, and how it is built49 / 100 · Range / mixed
The Crack Score is a deterministic 0 to 100 conviction number. Here is exactly what moved it for INDGN, so the figure is a transparent signal rather than a vibe.
Base 50, adjusted by the factors above and clamped to 0 to 100. How the Crack Score works.
The F&O viewHorizon · swing
How the futures and options structure on INDGN reads right now.
The editorial price read on INDGN is mixed. Strike-level option inventory is unavailable, so the page withholds writer, wall and pin claims. Single-stock F&O on INDGN can be thinner than index F&O, so the desk weights price and filed evidence over raw OI. This is not a derivatives trade recommendation.
Why it movedLatest editorial line
The most recent BazaarBaazi read on what is driving INDGN.
Systematic read: a disclosed, data-only model on real 1-year price structure.
Read in Systematic Read on 21 Jul 2026. Why INDGN moved, the living explainer, tracks every move on one URL.
Latest filed resultsQ4 FY26
Indegene Limited's most recent quarter, parsed straight from the official BSE filing. Every figure links back to its primary source.
Result Pulse
0 / 100Revenue
Rs 1,003 crNet profit
Rs 80 crEPS (quarter)
Rs 3.32| Growth | YoY | QoQ |
|---|---|---|
| Revenue | n/a | n/a |
| Net profit | n/a | n/a |
| Net margin | n/a | |
Figures are the Q4 FY26 result for Indegene Limited, parsed straight from the official BSE integrated filing and verified to the paisa. The EPS shown is for the quarter, not a trailing-twelve-month figure, so it is not a P/E input.
Earnings history, every filed quarter9 quarters on record
Indegene Limited's official quarterly revenue, EPS and Result Pulse trail, every quarter the desk holds from the verified filings export, back to 31 Mar 2024. These are quarterly facts, not TTM valuation inputs.
INDGN official result trail
9 quarters
Quarterly figures only: revenue, net profit and EPS are copied from official filings. EPS here is not trailing twelve month EPS and is not used for valuation.
| Quarter | Revenue | EPS | PAT YoY | Pulse | Source |
|---|---|---|---|---|---|
| Q4 FY26ended 31 Mar 2026 / Consolidated, audited | Rs 1,003 cr | Rs 3.32 | -32.2% | 44/100 | Filing |
| Q3 FY26ended 31 Dec 2025 / Consolidated, audited | Rs 942 cr | Rs 4.29 | n/a | 50/100 | Filing |
| Q2 FY26ended 30 Sep 2025 / Consolidated, audited | Rs 804 cr | Rs 4.26 | n/a | 44/100 | Filing |
| Q1 FY26ended 30 Jun 2025 / Consolidated, audited | Rs 761 cr | Rs 4.86 | n/a | 58/100 | Filing |
| Q4 FY25ended 31 Mar 2025 / Consolidated, audited | Rs 756 cr | Rs 4.91 | n/a | 58/100 | Filing |
| Q3 FY25ended 31 Dec 2024 / Consolidated, audited | Rs 720 cr | Rs 4.59 | n/a | n/a | Filing |
| Q2 FY25ended 30 Sep 2024 / Consolidated, audited | Rs 687 cr | Rs 3.84 | n/a | n/a | Filing |
| Q1 FY25ended 30 Jun 2024 / Consolidated, audited | Rs 677 cr | Rs 3.79 | n/a | n/a | Filing |
| Q4 FY24ended 31 Mar 2024 / Consolidated, audited | Rs 673 cr | Rs 4.27 | n/a | n/a | Filing |
The official financialsFiled to 31 Mar 2026
Indegene Limited's statements as filed: trailing twelve month P&L, the balance sheet, and the cash engine. Parsed from official XBRL, shown in crore.
Trailing twelve months, on filed quarters
Revenue (TTM)
3,511 crNet profit (TTM)
401 crEBIT (TTM)
544 crProfit before tax (TTM)
525 crNet margin (TTM)
11.4%Finance costs (TTM)
19.3 crBalance sheet, as filed 2026-03-31
Total assets
4,620 crShareholder equity
3,139 crTotal borrowings
0.0 crCash and equivalents
301 crInventory
0.0 crTrade receivables
982 crThe cash engine, latest filed year
Operating cash flow
651 crCapex
44.3 crFree cash flow
607 crInvesting flow
512 crFinancing flow
82.6 crAnnual trail, filed year over filed year
| Year | Revenue | Net profit | Equity | Borrowings | CFO |
|---|---|---|---|---|---|
| FY26 | 3,511 cr | 401 cr | 3,139 cr | 0.0 cr | 651 cr |
| FY25 | 2,839 cr | 407 cr | 2,616 cr | 0.0 cr | 442 cr |
| FY24 | 2,590 cr | 337 cr | 1,429 cr | 403 cr | 508 cr |
Every figure is parsed from Indegene Limited's official NSE XBRL filings by the BazaarBaazi earnings lab and shown in crore rupees. Display data, not a valuation model input.
Management on record10 earnings calls
Every INDGN earnings call BazaarBaazi has indexed, latest 31 May 2026. Read management in its own words, straight from the filed transcript.
Indegene Limited earnings calls on record
10 calls since 30 Jun 2024
Show 2 older calls
Each entry links to the transcript PDF the company filed with the exchange. Primary sources, in management's own words.
What changed1 disclosure
Every recent official filing from Indegene Limited, straight from the exchange feed, with the BazaarBaazi Event Heat on the disclosure flow.
Indegene Limited's most recent official filing is a Earnings dated 31 Mar 2026.
Event Heat
61 / 100Event Heat is a dated net read of Indegene Limited's last 180 days of official disclosures, balancing the constructive filings against the ones to watch. It is a signal from what the company has filed, not investment advice. Every line above links to its official exchange filing, and the full market desk is at the disclosures hub.
Key fundamentalsEditorial reference
The anchor data BazaarBaazi references when reading the INDGN chart. Not a substitute for a registered research note.
| Ticker | INDGN |
|---|---|
| Full name | Indegene Limited |
| Sector | Healthcare |
| Index class | MID CAP |
| ISIN | INE065X01017 |
| Market-cap band | ~12,189 cr (indicative) |
| Last referenced level | Inside latest show |
| Last session move | Not referenced this cycle |
| Editorial line in | Systematic Read on 21 Jul 2026 |
| Aliases tracked | INDGN |
Reference chartLevels in show
The daily frame the desk reads on INDGN.
FAQ11 reader questions · AEO-eligible
The line on INDGN, distilled and schema-marked for AI Overview, Perplexity, and reader search.
What is the INDGN share price target for 2026?
BazaarBaazi does not publish a SEBI-registered price target on INDGN. The desk reads structural support and resistance inside each show against the printed spot; the most recent editorial line is Systematic Read on 21 Jul 2026.
What is BazaarBaazi's Crack Score for INDGN?
The BazaarBaazi Crack Score for INDGN is 49 out of 100 as of 21 Jul 2026, a range / mixed reading. It is a computed conviction number from the signed stance, how consistent the recent verdicts have been, the quality of the printed structure, and how fresh the review is. It is a transparency signal, not investment advice.
What is the F&O view on INDGN?
Strike-level option inventory for INDGN is unavailable, so BazaarBaazi withholds participant, direction and positioning claims. The editorial chart stance is not substituted for an option-chain observation.
What sector is INDGN in and which peers does BazaarBaazi track?
INDGN sits in Healthcare (mid cap), indicative market cap ~12,189 cr (indicative), ISIN INE065X01017. The peers BazaarBaazi reads alongside it are GLAND PHARMA LIMITED, Eris Lifesciences Limited, ACUTAAS CHEMICALS LIMITED. A systematic, data-only read on Indegene Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
How often is the INDGN view updated?
This page is one evergreen URL refreshed in place. The Crack Score and levels re-compute on every BazaarBaazi end-of-day run, and the dated stamp shows the last refresh. The latest signed verdict on INDGN is mixed, published in Systematic Read on 21 Jul 2026.
Is INDGN a qualifying setup on the BazaarBaazi scanner right now?
On the 2026-07-21 run of the 500-name BazaarBaazi setup scanner, Indegene Limited sits in the Scanned tier with a setup score of 55/100 (technical 80, fundamental 33). The scanner is a deterministic engine over real OHLCV and official filings, refreshed nightly, and it is a signal rather than investment advice.
Where can I read Indegene Limited's earnings call transcripts?
BazaarBaazi indexes 10 INDGN earnings calls going back to 2024-06-30, latest 2026-05-31. Every entry on this page links straight to the transcript PDF the company filed with the exchange, so you read management in the primary source.
What was Indegene Limited's Q4 FY26 net profit?
Indegene Limited reported a net profit of Rs 80 cr for Q4 FY26 (the quarter ended 31 March 2026). The figure is from the company's official NSE filing.
What was Indegene Limited's Q4 FY26 revenue?
Indegene Limited reported revenue of Rs 1,003 cr for Q4 FY26. The figure is from the company's official NSE filing.
How does BazaarBaazi rate Indegene Limited's Q4 FY26 result?
BazaarBaazi gives Indegene Limited's Q4 FY26 result a Result Pulse of 0 out of 100, with a verdict of Insufficient data. The Result Pulse is a BazaarBaazi editorial score for the quality of the filed result, not investment advice.
What has Indegene Ltd announced recently?
The most recent official filing on record for Indegene Ltd is an earnings dated 31 Mar 2026. It is the company's own earnings disclosure to the exchange, and it links to that filing on the BazaarBaazi stock page rather than to any third-party summary.
Related stock views
The names BazaarBaazi reads alongside INDGN, each a living view refreshed every end-of-day run.